Ratings JSR Corporation

Equities

4185

JP3385980002

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-14 am EDT			5-day change	1st Jan Change
4,336 ^JPY	+0.02%		+0.05%	+7.86%

May. 09	JSR to Seek Shareholders Nod for Reverse Stock Split and Other Items on June 5	MT
May. 09	JSR to Cancel 764,410 Shares on June 26	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.

Weaknesses

With an expected P/E ratio at 63.35 and 27.8 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The valuation of the company is particularly high given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
JSR CORPORATION	+7.86%	5.76B	B+
ECOLAB INC.	+16.84%	66.18B	A-
SIKA AG	+1.13%	49.24B	A-
GIVAUDAN SA	+16.07%	41.72B	B+
FUJIFILM HOLDINGS CORPORATION	+22.44%	26.16B	A-
EMS-CHEMIE HOLDING AG	+11.60%	19.75B	C+
CELANESE CORPORATION	+3.13%	17.5B	B+
POSCO FUTURE M CO., LTD.	-23.12%	15.63B	A-
SYMRISE AG	+2.32%	15.43B	B+
ALBEMARLE CORPORATION	-8.98%	15.46B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes